About Palisade Bio
Palisade Bio is a company based in Carlsbad (United States) founded in 2005.. The company has 8 employees as of December 31, 2024. Palisade Bio offers products and services including PDE4 Platform and PALI-2108. Palisade Bio operates in a competitive market with competitors including EsoCap Biotech, Nucliqbio, CJ HealthCare, Amyra and Carbiotix, among others.
- Headquarter Carlsbad, United States
- Employees 8 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Palisade Bio, Inc.
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-14.44 M-17.23as on Dec 31, 2024
-
EBITDA
$-14.86 M-15.69as on Dec 31, 2024
-
Latest Funding Round
$500 K (USD), Post-IPO
Jan 07, 2026
-
Investors
HHS
& 2 more
-
Employee Count
8
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Palisade Bio
Palisade Bio is a publicly listed company on the NASDAQ with ticker symbol PALI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Palisade Bio
Palisade Bio offers a comprehensive portfolio of products and services, including PDE4 Platform and PALI-2108. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for developing precision therapies in medicine
Pipeline product for ulcerative colitis treatment
Unlock access to complete
Unlock access to complete
Funding Insights of Palisade Bio
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $500,000
-
First Round
First Round
(01 Aug 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Post-IPO - Palisade Bio | Valuation |
investors |
|
| May, 2024 | Amount | Post-IPO - Palisade Bio | Valuation |
investors |
|
| Dec, 2022 | Amount | Post-IPO - Palisade Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Palisade Bio
Palisade Bio has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Onvida Health and Crohn's & Colitis Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Onvida Health is recognized for providing comprehensive healthcare services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Palisade Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Palisade Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Palisade Bio Comparisons
Competitors of Palisade Bio
Palisade Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EsoCap Biotech, Nucliqbio, CJ HealthCare, Amyra and Carbiotix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Topical drug delivery platform for upper GI disorders is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for gut health are developed using metagenomics.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for treating gastrointestinal disorders
|
|
| domain | founded_year | HQ Location |
Pioneers enzyme supplementation for general health, nutrition, and food sensitivities.
|
|
| domain | founded_year | HQ Location |
Prebiotic ingredients and consumer products for microbiome health are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Palisade Bio
Frequently Asked Questions about Palisade Bio
When was Palisade Bio founded?
Palisade Bio was founded in 2005 and raised its 1st funding round 12 years after it was founded.
Where is Palisade Bio located?
Palisade Bio is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Who is the current CEO of Palisade Bio?
Thomas Hallam is the current CEO of Palisade Bio.
How many employees does Palisade Bio have?
As of Dec 31, 2024, the latest employee count at Palisade Bio is 8.
What does Palisade Bio do?
Palisade Bio was founded in 2005 and is based in Carlsbad, United States. Operations focus on the biotechnology sector, where therapeutics for gastrointestinal disorders are developed. The lead candidate, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug targeted at moderate-to-severe ulcerative colitis. Another drug, GT-1908, addresses fibrostenotic Crohns disease. Development activities center on advancing these prodrugs through clinical stages.
Who are the top competitors of Palisade Bio?
Palisade Bio's top competitors include Carbiotix, EsoCap Biotech and CJ HealthCare.
What products or services does Palisade Bio offer?
Palisade Bio offers PDE4 Platform and PALI-2108.
Is Palisade Bio publicly traded?
Yes, Palisade Bio is publicly traded on NASDAQ under the ticker symbol PALI.
Who are Palisade Bio's investors?
Palisade Bio has 3 investors. Key investors include HHS, Onvida Health, and Crohn's & Colitis Foundation.
What is Palisade Bio's ticker symbol?
The ticker symbol of Palisade Bio is PALI on NASDAQ.